The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.

D.J. Gaughan, L.A.J. Kluijtmans, S. Barbaux, D. McMaster, Ian Young, John Yarnell, Alun Evans, A.S. Whitehead

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{6ba778fb87594e54acef6a0f53a3d37d,

title = "The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.",

author = "D.J. Gaughan and L.A.J. Kluijtmans and S. Barbaux and D. McMaster and Ian Young and John Yarnell and Alun Evans and A.S. Whitehead",

year = "2001",

language = "English",

volume = "157",

pages = "451--456",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.

AU - Gaughan, D.J.

AU - Kluijtmans, L.A.J.

AU - Barbaux, S.

AU - McMaster, D.

AU - Young, Ian

AU - Yarnell, John

AU - Evans, Alun

AU - Whitehead, A.S.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0034904708&partnerID=8YFLogxK

M3 - Article

SN - 0021-9150

VL - 157

SP - 451

EP - 456

JO - Atherosclerosis

JF - Atherosclerosis

IS - 2

ER -